ICCM
Income statement / Annual
Last year (2024), IceCure Medical Ltd's total revenue was $3.29 M,
an increase of 1.92% from the previous year.
In 2024, IceCure Medical Ltd's net income was -$15.32 M.
See IceCure Medical Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$3.29 M |
$3.23 M |
$3.09 M |
$4.14 M |
$4.08 M |
$1.66 M |
$1.07 M |
$689,377.00 |
$625,487.00 |
$762,873.00 |
| Cost of Revenue |
$1.84 M
|
$1.93 M
|
$1.64 M
|
$1.94 M
|
$1.43 M
|
$1.08 M
|
$623,174.00
|
$514,443.00
|
$403,993.00
|
$486,210.00
|
| Gross Profit |
$1.45 M
|
$1.30 M
|
$1.45 M
|
$2.20 M
|
$2.66 M
|
$576,413.00
|
$448,728.00
|
$174,934.00
|
$221,494.00
|
$276,663.00
|
| Gross Profit Ratio |
0.44
|
0.4
|
0.47
|
0.53
|
0.65
|
0.35
|
0.42
|
0.25
|
0.35
|
0.36
|
| Research and Development Expenses |
$7.10 M
|
$8.27 M
|
$9.12 M
|
$5.88 M
|
$4.08 M
|
$2.85 M
|
$1.94 M
|
$1.50 M
|
$1.66 M
|
$980,874.00
|
| General & Administrative Expenses |
$8.91 M
|
$4.17 M
|
$5.86 M
|
$4.13 M
|
$1.76 M
|
$1.32 M
|
$1.07 M
|
$1.02 M
|
$943,950.00
|
$1.34 M
|
| Selling & Marketing Expenses |
$1.14 M
|
$4.44 M
|
$3.20 M
|
$1.92 M
|
$1.11 M
|
$1.02 M
|
$612,553.00
|
$319,657.00
|
$716,996.00
|
$1.49 M
|
| Selling, General & Administrative Expenses |
$10.05 M
|
$8.60 M
|
$9.06 M
|
$6.04 M
|
$2.87 M
|
$2.34 M
|
$1.68 M
|
$1.34 M
|
$1.66 M
|
$2.82 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$70,594.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$17.15 M
|
$16.88 M
|
$18.18 M
|
$11.92 M
|
$7.02 M
|
$5.19 M
|
$3.62 M
|
$2.84 M
|
$3.33 M
|
$3.81 M
|
| Cost And Expenses |
$18.99 M
|
$18.81 M
|
$19.82 M
|
$13.86 M
|
$8.45 M
|
$6.27 M
|
$4.24 M
|
$3.35 M
|
$3.73 M
|
$4.29 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$4,042.85
|
-$178,757.98
|
$531.04
|
$2,014.04
|
$3,899.55
|
$8,709.77
|
| Interest Expense |
$0.00
|
$0.00
|
$239,000.00
|
$0.00
|
$31,720.00
|
$22,813.00
|
$63,459.00
|
$58,119.00
|
$154,942.00
|
$198,531.00
|
| Depreciation & Amortization |
$332,000.00
|
$323,000.00
|
$248,000.00
|
$127,000.00
|
$63,000.00
|
$155,365.00
|
$30,800.00
|
$33,375.00
|
$54,073.00
|
$63,017.00
|
| EBITDA |
-$15.36 M |
-$15.25 M |
-$16.49 M |
-$9.60 M |
-$4.08 M |
-$4.60 M |
-$3.42 M |
-$2.75 M |
-$3.03 M |
-$3.69 M |
| EBITDA Ratio |
-4.67
|
-4.72
|
-5.35
|
-2.32
|
-1.06
|
-2.79
|
-3.19
|
-3.99
|
-4.85
|
-4.5
|
| Operating Income Ratio |
-4.77
|
-4.82
|
-5.43
|
-2.35
|
-1.07
|
-2.78
|
-2.96
|
-3.87
|
-4.96
|
-4.63
|
| Total Other Income/Expenses Net |
$378,000.00
|
$924,000.00
|
-$239,000.00
|
-$171,000.00
|
$412,000.00
|
-$165,184.24
|
-$363,761.88
|
-$210,898.84
|
-$166,640.67
|
-$222,867.77
|
| Income Before Tax |
-$15.32 M
|
-$14.65 M
|
-$16.98 M
|
-$9.90 M
|
-$4.69 M
|
-$4.77 M
|
-$3.53 M
|
-$2.88 M
|
-$3.27 M
|
-$3.75 M
|
| Income Before Tax Ratio |
-4.65
|
-4.54
|
-5.5
|
-2.39
|
-1.15
|
-2.88
|
-3.3
|
-4.17
|
-5.23
|
-4.92
|
| Income Tax Expense |
$0.00
|
$0.00
|
$239,000.00
|
$171,000.00
|
$86,765.00
|
-$13,572.83
|
-$1.13 M
|
-$640,929.57
|
-$458,761.14
|
-$614,086.32
|
| Net Income |
-$15.32 M
|
-$14.65 M
|
-$17.22 M
|
-$10.07 M
|
-$4.78 M
|
-$4.76 M
|
-$3.53 M
|
-$2.88 M
|
-$3.27 M
|
-$3.75 M
|
| Net Income Ratio |
-4.65
|
-4.54
|
-5.58
|
-2.43
|
-1.17
|
-2.87
|
-3.3
|
-4.17
|
-5.23
|
-4.92
|
| EPS |
-0.31 |
-0.32 |
-0.47 |
-0.35 |
-0.28 |
-0.35 |
-0.3 |
-0.46 |
-0.62 |
-1.15 |
| EPS Diluted |
-0.31 |
-0.32 |
-0.47 |
-0.35 |
-0.28 |
-0.35 |
-0.3 |
-0.46 |
-0.62 |
-1.15 |
| Weighted Average Shares Out |
$49.23 M
|
$45.64 M
|
$37.02 M
|
$28.55 M
|
$17.13 M
|
$13.62 M
|
$11.67 M
|
$6.26 M
|
$5.30 M
|
$3.27 M
|
| Weighted Average Shares Out Diluted |
$49.23 M
|
$45.64 M
|
$37.02 M
|
$28.55 M
|
$17.13 M
|
$13.62 M
|
$11.67 M
|
$6.26 M
|
$5.30 M
|
$3.27 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
